Navigate on publiceye.ch
Quick navigation
Content
Homepage
Navigation
Sitemap
Search
Main navigation
What we do
Get involved
About Public Eye
Our Publications
Reports & Factsheets
Newsletter
Social Media
Our topics
Commodities
Corruption
Fashion
Investigation Award
Pesticides
Pharma
Seeds
Soft Commodities
Trade policy
War on Ukraine
Archive
Close
Membership
Become a member
Donations and Bequests
Donate
Legacies and bequests
Get involved
Follow us
Close
About us
Portrait
Organisation
Team
The Governing Board
History
Jobs
Service
Media corner
Contact
Close
Open search forn
Reports & Factsheets
en
Change language. Current language: English
Deutsch
Français
English
Close
Donate
Open menu
Search term
Search
Close search
Search term
Search
What we do
Our Publications
Reports & Factsheets
Newsletter
Social Media
Our topics
Commodities
Corruption
Fashion
Investigation Award
Pesticides
Pharma
Seeds
Soft Commodities
Trade policy
War on Ukraine
Archive
Get involved
Membership
Become a member
Donations and Bequests
Donate
Legacies and bequests
Get involved
Follow us
About Public Eye
About us
Portrait
Organisation
Team
The Governing Board
History
Jobs
Service
Media corner
Contact
Change language. Current language: English
DE
FR
EN
Close menu
Tag
Pharma
Leak on free trade agreement with India
Switzerland protects pharma at the expense of the poorest patients
14. February 2024
40 to 90 percent profit margins
Astronomical profit margins of pharmaceutical companies are partly to blame for the premium shock
12. September 2022
Report
Properly unhealthy
2022
Trips Waiver
WTO: Switzerland blocks the COVID-19 waiver until the end
10. June 2022
Webinar
The Power of Law part II. Presenting PAF’s Guidelines for Legal Action for NGOs
27. January 2022
High Level Dialogue
TRIPS Waiver: If Not Now, Then When?
4. May 2021
Report
Big Pharma takes it all
2021
Patent abuse, lack of transparency, profiteering
How Covid-19 exposes Big Pharma’s harmful business strategies
9. March 2021
Affordable drugs
How dare you, Novartis?
28. February 2020
Victory for public health
Novartis drops the Kymriah patent that was opposed by Public Eye
16. December 2019
Page navigation
1
2
3
4
5
6
Next page>